"DIEX Recherche est une entreprise privée sherbrookoise de recherche clinique conduisant des essais de phase I à IV au Québec. Participer à une étude clinique c’est en apprendre davantage sur sa condition de santé tout en ayant un accès privilégié à une équipe médicale composée de médecins et d’infirmiers(ères) qualifiés. C’est aussi la possibilité d’essayer un traitement novateur gratuitement. La participation à un projet est toujours volontaire et n’implique aucun coût de votre part. Notre équipe a la flexibilité de s’adapter à vos disponibilités pour les rendez-vous et nous remboursons tous les frais reliés à vos déplacements."

During the past decade, Diex Research Sherbrooke Inc. conducted 68 clinical trials. In the 10-year time frame, 68 clinical trials started and 47 clinical trials were completed, i.e. on average, 69.1% percent of trials that started reached the finish line to date. In the past 5 years, 36 clinical trials started and 29 clinical trials were completed. i.e. 80.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Diex Research Sherbrooke Inc." #1 sponsor was "Pfizer" with 44 trials, followed by "Eli Lilly and Company" with 5 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Medicago" with 3 trials sponsored and "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 3 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 36 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Diex Research Sherbrooke Inc." #1 collaborator was "PPD" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "ArthroLab Inc." with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator and "Diex Research Sherbrooke Inc." with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Diex Research Sherbrooke Inc." are "Alzheimer Disease" (9 trials), "Psoriasis" (6 trials), "Alzheimer's Disease" (5 trials), "Migraine" (4 trials) and "Osteoarthritis, Knee" (4 trials). Many other conditions were trialed in "Diex Research Sherbrooke Inc." in a lesser frequency.

Most popular intervention types in "Diex Research Sherbrooke Inc." are "Drug" (83 trials), "Biological" (15 trials), "Other" (14 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (51 trials), "placebo" (6 trials), "PF-06700841" (4 trials), "Saline" (3 trials) and "30 µg/strain of Quadrivalent VLP Vaccine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Diex Research Sherbrooke Inc." are 92 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Diex Research Sherbrooke Inc.". undefined are not yet recruiting, 14 are recruiting, 10 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 60 completed trials in Diex Research Sherbrooke Inc., 1 suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Diex Research Sherbrooke Inc., 3 "Phase 1" clinical trials were conducted, 43 "Phase 2" clinical trials and 45 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 2 trials that are defined as “Not Applicable".

Diex Research Sherbrooke Inc. has several departments that took part in Clinical trials: "Diex Recherche Joliette" - 2 trials